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Two-dimensional (2D) culture of cancer cells in vitro does not recapitulate the three-dimensional (3D)
architecture, heterogeneity and complexity of human tumors. More representative models are required
that better reﬂect key aspects of tumor biology. These are essential studies of cancer biology and
immunology as well as for target validation and drug discovery. The Innovative Medicines Initiative (IMI)
consortium PREDECT (www.predect.eu) characterized in vitro models of three solid tumor types with the
goal to capture elements of tumor complexity and heterogeneity. 2D culture and 3D mono- and stromal co-
cultures of increasing complexity, and precision-cut tumor slice models were established. Robust
protocols for the generation of these platforms are described. Tissue microarrays were prepared
from all the models, permitting immunohistochemical analysis of individual cells, capturing heterogeneity.
3D cultures were also characterized using image analysis. Detailed step-by-step protocols, exemplary
datasets from the 2D, 3D, and slice models, and reﬁned analytical methods were established and are
presented.
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Design Type(s)
cell type comparison design • protocol optimization objective • compound
treatment design • in vitro design
Measurement Type(s) imaging assay
Technology Type(s) image acquisition and analysis
Factor Type(s)
cell culture • extracellular matrix • cancer cell line • compound based
treatment • image creation device
Sample Characteristic(s) LNCaP cell • MCF-7 cell • NCI-H1437 cell
Background & Summary
Carcinomas, also known as solid tumors, have a complex microenvironment, are cellularly
heterogeneous, and have a three-dimensional (3D) architecture1. Ideally, laboratory models of these
cancers should attempt to capture key aspects of this complexity and architecture. Despite the wealth of
data generated, and strong recommendations to upgrade cell culture models from those growing in two
dimensions (2D) (e.g., cellular monolayers on plastic substrates) to 3D models2, few of these more
complex 3D model systems have been used to investigate cancer cell biology in vitro. Neither have they
been routinely incorporated into the drug screening cascade alongside standard 2D models despite
consistent evidence suggesting that preclinical models largely fail to predict drug efﬁcacy3.
Reproducibility, cost, and limited throughput are some of the issues precluding their routine use. A
detailed characterization and cross-comparison of some more complex models with 2D models is
pertinent. The public-private PREDECT consortium (www.predect.eu) set out to characterize an array of
in vitro models for oncology research, attempting to construct models better able to capture the
complexity of solid cancers4. Models were generated from a range of breast, prostate, and lung cancer cell
lines as well as from patient-derived xenograft (PDX) and a genetically engineered mouse model
(GEMM). Starting from conventional 2D monocultures, the complexity of the models was increased
stepwise to include stromal cells in 2D co-cultures, and then in 3D cultures. The latter cultures were
generated as free-ﬂoating spheroids (‘ﬂoaters’), microencapsulated into inert hydrogels (alginate) and
grown in stirred-tank bioreactors (‘alginate-BR’), or embedded in extracellular matrix (ECM), all in the
presence or absence of stromal cells5–8. Cell growth of the 2D/3D models, as well as their response to
standard of care (SOC) drugs or chemotherapy were monitored by measurement of ﬂuorescence. At
stationary growth phase, (co-)cultures were analyzed in more depth by ﬂuorescence imaging of in situ
ﬁxed cultures, as well as immunohistochemistry (IHC) on parafﬁn embedded samples processed into
tissue microarrays (TMAs).
Precision-cut tissues slices derived from a GEMM or from PDX xenografts were also generated. The
slices capture the native tumor microenvironment and any tumor heterogeneity that may exist and, as
with the 2D and 3D models, were preserved as TMAs9.
The aim of this paper is to provide detailed descriptions of the protocols developed within the
PREDECT consortium, methods to monitor culture viability status and to follow treatment responses.
Moreover, raw data examples from PREDECT’s 2D/3D cell culture characterizations are provided for
guidance. This guidance should allow other research groups to repeat and extend the data generated by
the PREDECT consortium.
Methods
The methods section contains step-by-step protocols of the methods established and validated by the
PREDECT consortium, starting with cultivation protocols and ending with analytical methods.
An overview is presented in Fig. 1. These methods are expanded versions of descriptions in published
work5,9.
Tissue culture protocols
Cell lines used in the 2D and 3D experiments were transduced with genetic constructs driving expression
of ﬂuorescent proteins, in order to allow monitoring of the cells during cultivation. Since no common
protocol to generate labeled cell lines was generated, but a variety of working protocols exist (see also5),
this part of the procedure will not be described in detail here.
2D cell culture. 2D cell cultures should be plated in black 96-well clear-bottom microplates (e.g.,
Greiner Bio One #655-088). All the different plates used in our study are listed below in Table 1. When
performing experiments with several 96-well plates, drawing the layout of each plate on the lids simpliﬁes
and speeds up the pipetting process. The outer wells should not be used due to the evaporation edge effect
www.nature.com/sdata/
SCIENTIFIC DATA | 4:170170 | DOI: 10.1038/sdata.2017.170 2
during long term culturing.
Step 1: Prepare fresh cell culture medium without phenol red prior to each experiment.
Step 2: Trypsinize and collect tumor cells and ﬁbroblasts in 50 ml tubes, centrifuge 3 min at 450 × g.
Resuspend cell pellets in 1–5 ml medium depending on the cell lines used.
*If experiments are conducted at a lower serum concentration than during regular culture, resuspend cell
pellets in serum-free medium, centrifuge once more and resuspend in medium containing the desired serum
concentration.
Determine the concentration for each cell line and prepare adequate dilutions for monocultures
and co-cultures in medium, calculating 200 μl per well.
*Examples for cell numbers and ratios are presented in Table 2. The cell number and ratio for every new cell
line/combination will have to be optimized. For tumor cell numbers, extremes of 5-times higher or lower
than suggested in Table 2 may be tested, for ratios, a useful range is between 10:1 and 1:10.
Step 3: Seed the desired number of cells per well in 200 μl medium with all supplements required. Add
200 μl medium only to each control well.
*Pipetting with a multichannel pipet from a reservoir is an easy and fast approach to ﬁll the plates.
Step 4: Fill the outer and additional empty wells with 200 μl of PBS before placing the plates in a
humidiﬁed incubator at 37 °C and 5% CO2. Do not refresh the medium during cultivation as this
may cause cells to detach and disturb the ﬂuorescence growth measurements.
Fluorescence measurements
Step 5: Measure the baseline ﬂuorescence values after overnight incubation with a plate reader. See
Table 3 for plate readers used in this study.
*Excitation and emission settings depend on the construct the cells have been transduced with, e.g., 540/587
nm for RFP and 488/525 nm for GFP. See Table 3 for additional settings.
Repeat measurements every 2–3 days for growth curve construction until the cultures reach
stationary phase.
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Figure 1. Models covered in this manuscript. A graphical representation of the cell culture platforms and
their duration, as well as analyzes for which protocols and data are provided. Modiﬁed from ref. 5.
www.nature.com/sdata/
SCIENTIFIC DATA | 4:170170 | DOI: 10.1038/sdata.2017.170 3
Drug treatment
Step 6: Seed cells in 100 μl medium per well and add after overnight incubation 100 μl of 2X compound
concentration to each well.
*Desired compound concentrations should be prepared in DMSO, unperturbed controls should receive
medium with the same DMSO concentration. Since cell lines may react differently to the concentration of
DMSO, maximally tolerated DMSO concentrations should be determined before starting perturbation
experiments.
Measure the baseline ﬂuorescence values and repeat every 2–3 days. Do not refresh the medium,
unless absolutely required for cell growth.
3D ﬂoater cultures. 3D ﬂoater cultures may be cultivated in 384 well ultra-low attachment (ULA;
Corning #3830) or agarose-coated plates (Greiner Bio-One #781090). Supplementary Figure S1 illustrates
a suggestion of a layout to seed tumor cells in mono- and two different co-cultures with stromal cells in a
single 384 well plate.
Step 1: Prepare fresh cell culture medium without phenol red prior to each experiment.
When working with agarose-coated plates, coat each well with 10 μl 1.5% agarose in medium,
seal the plates after 2 h with an adhesive cover and store overnight at 4 °C.
Step 2: Trypsinize and collect tumor cells and ﬁbroblasts in 50 ml tubes, centrifuge for 3 min at 450 × g.
Resuspend cell pellets in 1–5 ml medium depending on the cell lines used.
*If experiments are conducted at a lower serum concentration than during regular culture, resuspend cell
pellets in serum-free medium, centrifuge once more and resuspend in medium containing the desired serum
concentration.
Step 3: Determine the concentration for each cell line and prepare adequate dilutions for monocultures
and co-cultures in medium, calculating 50 μl per well for an ULA plate or 40 μl for an agarose-
coated plate. Pre-warm agarose-coated plates to RT before seeding the cells.
Culture model Plate type Manufacturer
2D Black 96-well clear ﬂat bottom e.g., Greiner Bio One #655-088
3D matrix embedded Black 96-well clear ﬂat bottom e.g., Greiner Bio One #655-088
3D ﬂoaters Black 384-well ultra-low attachment clear round bottom e.g., Corning #3830
Table 1. Microwell plates used for plate based ‘static’ PREDECT culture models. Note: for tissue slices,
any microwell plates of appropriate volume may be used since slices will not adhere directly to the plate surface.
2D 3D ﬂoater 3D embedded 3D bioreactor
TC (/well) TC:SC FBS (%) TC (/well) TC:SC FBS (%) TC (/well) TC:SC FBS (%) TC (/ml) TC:SC FBS (%) Medium
Breast 6,000 03:01 10 1,000 03:01 10 10,000 10:01 2 20,000 01:01 10 DMEM
Prostate 10,000 10:01 2 1,000 10:01 2 10,000 10:01 2 N/A N/A N/A RPMI
Lung 10,000 10:01 10 400/200* 01:01 10 10,000 10:01 2 20,000 01:01 10 RPMI
Table 2. Experimental 2D/3D cell culture conditions used in the PREDECT study. TC: tumor cells; SC:
stromal cells. *mono/co-cultures; N/A: Not applicable (not performed). Taken from ref. 1.
Plate Reader Filters
Instrument Label Excitation (nm) Cut-off Emission (nm)
BioTek (Synergy HT) GFP 485/20 — 528/20
RFP 530/25 — 590/35
Tecan (Inﬁnite M200) GFP 488 — 509
GFP 485 — 535
RFP* 554 — 581
Molecular Devices (SpectraMax M2e) GFP 540 570 587
RFP 488 515 525
PE-Wallach (EnVision 2,100) RFP* 531 — 590
Table 3. Set-up of plate readers for real-time growth monitoring. *dTomato. Taken, with modiﬁcations,
from ref. 5.
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*Examples for cell numbers and ratios are presented in Table 2. The cell number and ratio for every new cell
line/combination will have to be optimized. For tumor cell numbers, extremes of 5-times higher or lower
than suggested in Table 2 may be tested, for ratios, a useful range is between 10:1 and 1:10.
Mix the suspension well, and transfer 50 μl to each well of an ULA plate or 40 μl to an agarose-
coated plate. Fill the control wells with 50 μl per 40 μl medium and outer wells with PBS.
Step 4: Centrifuge the ULA plate at 380 × g (agarose-coated at 170 × g) for 1 min at RT. Incubate the
plate in a humidiﬁed incubator at 37 °C. Carefully refresh half of the medium twice a week. This
can be performed by a washer or manually with a multichannel pipette.
*When refreshing the plates manually take great care not to lose the spheroids in the process. One option to
prevent this is pipetting the old medium to a second plate and then measure the ﬂuorescence in the second
plate in order to identify wells where ﬂoaters accidentally have been removed.
Fluorescence measurements
Step 5: Measure the baseline ﬂuorescence values after overnight incubation with a plate reader. See
Table 3 for plate readers used in this study.
*Excitation and emission settings depend on the construct the cells have been transduced with, e.g., 540/587
nm for RFP and 488/525 nm for GFP. See Table 3 for additional settings.
Repeat measurements every 2–3 days for growth curve construction until the cultures reach
stationary phase.
Drug Treatment
Step 6: When tumor cells enter exponential growth, add 25 μl medium including the compound at 3X
concentration (should result in 1X concentration in 75 μl). Refresh half of the medium with 1X
compound concentration twice a week.
3D alginate-embedded stirred-tank bioreactor cultures (alginate-BR). This protocol describes
the set-up for one 125ml spinner vessel with straight blade paddle impeller (Corning Life Sciences; BR).
Step 1: Prepare fresh cell culture medium without phenol red prior to each experiment.
Step 2: Collect the tumor cells as described in the 2D cell culture section and determine cell
concentration. Inoculate single cell suspension (0.2 × 106 cell per ml) in the 125 ml BR and
induce cell aggregation by stirring the culture at 80 rpm, for 24 h.
*Stirring and aggregation time need to be adjusted for each cell line. The goal is to induce compacted
spheroids with a diameter of 100 to 300 μm within 4 days of culture, while limiting clumping and fusion7.
Step 3: Prepare the microencapsulation solutions: 0.9% NaCl (w/v) and 100 mM CaCl2/10 mM HEPES
(pH 7.4) or 20 mM BaCl2 (for full buffer composition, see step 4). Prepare the Ultrapure Ca
2+
MVG alginate (PRONOVA UP MVG, #4200106 NovaMatrix, Pronova Biomedical, Oslo,
Norway) by dissolving the alginate powder in NaCl 0.9% (w/v) solution to a ﬁnal concentration
of 1.1% (w/v). Shake the alginate mixture overnight at 20 rpm.
Step 4: Collect tumor spheroids from the BR, centrifuge at 50 × g, 4 min, RT. Remove the supernatant,
wash with PBS without calcium and magnesium, and centrifuge the spheroid suspension as
before. Disperse tumor spheroids corresponding to 25 × 106 cells in 3 ml of 1.1% (w/v) Ultrapure
Ca2+ MVG alginate. For co-cultures, add stromal cells at this point, in a 1:1 proportion, to attain
50 × 106 total cells.
*The low tumor:stroma cell ratio (1:1) in the inert alginate hydrogels was selected since no overgrowth by
ﬁbroblasts has been observed in any of the tumor:stroma combinations tested so far, and higher tumor:
stroma cell ratios appeared to fail to appropriately stimulate tumor cells.
Microencapsulate using an electrostatic bead generator (Nisco VarV1, Zurich, Switzerland), and
a nozzle of 250 μm inner diameter, to obtain beads of a diameter of approximately 500 μm.
Alginate beads are cross-linked in either a 100 mM CaCl2/10 mM HEPES (pH 7.4) solution for
10 min or a 20 mM BaCl2 solution, adjusted to 290–300 mOsm using NaCl, buffered at pH 7.4
with 5 mM histidine, for 10 min.
*Calcium crosslinking has the advantage of being non-toxic. Also, it is easier to chelate and thus recover
embedded cells. However, calcium cannot be used with all culture media (e.g., in RPMI1640, calcium-
crosslinked capsules are chelated only after few days of culture).
*Barium crosslinking can be used with all culture media and provides stiffer capsules. However, it is harder
to chelate and thus more difﬁcult to recover embedded cells. Also, toxicity is higher in case of excessive
crosslinking.
The microencapsulated cultures are then washed three times in a 0.9% (w/v) NaCl solution and
ﬁnally equilibrated in culture medium before being transferred to the BR. Keep the
microencapsulated mono- and co-cultures in a humidiﬁed incubator, at 37 °C and 5% CO2,
for 20 days, with 50% medium exchange every 3–4 days.
Fluorescence measurements
Step 5: After overnight incubation, remove a sample from the bioreactor to measure the baseline
ﬂuorescence values with a plate reader. See Table 3 for plate readers used in this study.
*Excitation and emission settings depend on the construct the cells have been transduced with, e.g., 540/587
nm for RFP (dTomato) and 488/525 nm for GFP. See Table 3 for additional settings.
www.nature.com/sdata/
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Repeat measurements every 2–3 days for growth curve construction until the cultures reach
stationary phase.
Drug Treatment
Step 6: In order to determine dose-response curves and IC50/IC80 values, transfer a sample of the
alginate-BR cultures to 96-well plates when at exponential phase of growth.
*Using a small calibration curve, 10 capsules per well was determined to be in the middle of the linear phase
of the curve, thus allowing for a quantiﬁcation of both signal increase and decrease. In addition to an equal
number of capsules, the baseline ﬂuorescence signal was used to normalize the inter-well variability.
Add the test compound at different concentrations. Refresh 50% of the medium every 3–4 days
of culture.
*It is recommended to determine dose-response curves using this strategy. Once the drug concentration of
interest is known, the drug may be added directly to the stirred-tank culture.
3D matrix-embedded cell culture. This protocol is for approximately three 96-well plates with
Matrigel, Matrigel-collagen (mixed), and collagen cultures. Remaining Matrigel can be stored at 4 °C but
we recommend preparing fresh Matrigel for important experiments. 3D cell cultures should be plated in
black 96-well clear-bottom microplates (see Table 1). In the present protocol FBS was used at a
concentration of 2%, as we aimed to keep serum concentrations low to detect a possible crosstalk between
tumor cells, stromal cells and extracellular matrix components. See Supplementary Fig. S2 for a suggested
plate layout.
Step 1: Prepare fresh cell culture medium without phenol red prior to each experiment.
Leave Matrigel to thaw on ice, this can be done overnight if kept at 4 °C.
*Prepare Matrigel (Corning #356231 10.8 mgml−1) solution by diluting one 10 ml vial to 8 mgml−1 with
3060.2 μl 1X RPMI, 135 μl 100X Glutamax (2 mM), 34.8 μl 45% D-glucose (12 mM) and 270 μl FBS (2%).
Keep on ice in a 50 ml tube. When working with Matrigel at a different initial concentration the dilution
process will need to be adjusted to maintain the ﬁnal concentration of the additives.
*Prepare 10 ml of a 3 mgml−1 collagen I (BD Bioscience # 354236 3.8 mgml−1) solution containing 1 ml 10x
RPMI, 300 μl 1 M HEPES, 300 μl 7,5% sodium bicarbonate and 8 ml collagen in a 50 ml tube. Add 1M
NaOH until the pH is between 7.1–7.4, then add 200 μl FBS, top up to 10 ml with H2O, and mix gently.
Keep the solution on ice.
Pre-coat the wells with 30 μl of relevant matrix diluted 1:1 with RPMI (ﬁnal concentration:
Matrigel 4 mgml−1 and collagen 1.5 mgml−1) and centrifuge the plates 1 min at 975 × g to ensure
an even and complete coating of the whole well bottom. For mixed matrix dilute Matrigel with
collagen 1:1. Place the pre-coated plates in a humidiﬁed incubator at 37 °C for at least 30 min to
allow solidiﬁcation of the matrix before adding the cell suspension.
*This helps to prevent 2D growth of the cells on the bottom of the wells.
Step 2: Trypsinize and collect tumor cells and ﬁbroblasts in 50 ml tubes, centrifuge 3 min at 450 × g.
Resuspend cell pellets in 1–5 ml medium depending on the cell lines used.
*If experiments are conducted at a lower serum concentration than during regular culture, resuspend cell
pellets in serum-free medium, centrifuge once more and resuspend in medium containing the desired serum
concentration.
Step 3: Determine the concentration for each cell line and prepare adequate dilutions for monocultures
and co-cultures in medium, based upon 30 μl per well.
*Examples for cell numbers and ratios are presented in Table 2. The cell number and ratio for every new cell
line/combination will have to be optimized. For tumor cell numbers, extremes of 5-times higher or lower
than suggested in Table 2 may be tested, for ratios, a useful range is between 10:1 and 1:10.
Mix well before adding the same volume of relevant matrix. Mix gently with a multichannel
pipette and transfer 60 μl to each well. Add 60 μl matrix only to control wells and place the plates
in a humidiﬁed incubator at 37 °C for at least 90 min.
*It is recommended to put the assay plate on a heating block when preparing the cultures as this will speed
up setting of the matrix, and prevent the cells from sinking to the bottom of the well.
*When preparing mixed matrix, prepare the cell suspension in collagen and add an equal volume of
Matrigel. 10% extra-volume should be prepared due to the viscosity of the matrices.
Step 4: Add 90 μl of medium at room temperature (RT) on top of the matrix in each well. Fill the outer
and additional empty wells with 200 μl of PBS before placing the plates back in the humidiﬁed
incubator at 37 °C/5% CO2. Refresh the medium twice a week, preferably with the plates placed
on a heating block to prevent temperature drops. Tilt the plates slightly when removing the
medium to prevent damaging the 3D matrix.
Fluorescence measurements
Step 5: Measure the baseline ﬂuorescence values after overnight incubation with a plate reader. See
Table 3 for plate readers used in this study.
*Excitation and emission settings depend on the construct the cells have been transduced with, e.g., 540/587
nm for RFP and 488/525 nm for GFP. See Table 3 for additional settings.
Repeat measurements every 2–3 days for growth curve construction until the cultures reach
stationary phase.
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Drug Treatment
Step 6: When tumor cells enter exponential growth, remove the overlay medium and add a 2X
compound concentration (to compensate for the matrix volume) in 90 μl medium. Refresh the
medium with 1X compound concentration twice a week.
Tissue slice cultures from tumors grown in mice. Clean all instruments with 70% EtOH before use.
Step 1: Prepare media plates (described in Tables 1/4), placing 1.3 ml of media into each well of a 6 well
plate, or 0.5 ml into a 24 well plate. Then place an organotypic support in each well, and allow for
the system to equilibrate
*6 and 24 well organotypic support versions were used (Millipore, PICM 0RG 50 & PICM 012 50).
Step 2: Cull mouse and clean skin with 70% EtOH, using sterile dissection kit dissect tumor and place
immediately into ice cold Oncostore solution (OncoScience AG) or L-15 Leibovitz Medium
(Lonza)
Step 3: Prepare the vibrating microtome for use, cleaning all reusable parts with 70% EtOH.
*A Leica VT1200S vibratome was used for all tissue slice experiments in this manuscript. Other devices are
available, however, methods have to be adapted according to the manufacturer.
*Leica’s Vibrocheck device was used prior to each use to calibrate the vertical deﬂection, ensuring even
cutting of the blade
Step 4: Embed tumor in low temperature melting agarose in the desired orientation
*Remove excess connective tissue and liquid
*This step depends on tumor size and shape. If big enough and evenly shaped, the tumor does not have to
be embedded.
Step 5: Mount (embedded) tumors on the sample platform using cyanoacrylate glue (e.g., Rot1 Coll 1
(Carl Roth GmbH)).
*If using another vibrating microtome, place tumor in the cutting chamber.
Place sample platform with tissue in buffer tray, ﬁll with cold PBS supplemented with penicillin
(100 Uml−1; e.g., Gibco) and streptomycin (100 μgml−1; e.g., Gibco) to cover the tumor sample.
Step 6: Set slicing parameters and begin slicing.
*Settings need to be adjusted to the sample. The softer the tissue, the higher the amplitude and lower the
speed setting that should be used.
*As a starting point, these settings may be used: speed: 0.2 mm/s, amplitude: 1 mm, slice thickness: 250 μm
Use a probe to aid complete severance of the slice from the tumor.
Step 7: Remove slices from the machine using a spatula and probe, being careful not to pierce the slices,
and place them on organotypic supports.
*Avoid trapping air bubbles underneath the slice
*Ensure that ﬁlter supports are moistened with medium before use.
Step 8: Add a few drops of media on the air surface of the slice to ensure sample is moistened (see
Table 4 for media used).
Step 9: Place culture plate with slices in incubator
*37 °C and 5% CO2 in a humidiﬁed atmosphere under low oxygen (3–5% oxygen) or atmospheric oxygen
(21% oxygen)
Step 10: Remove 1/2 media every 24 h from the bottom of the well, adding 50 μl of media on top of the
slice to keep it moistened.
Analytical methods
Generation of growth curves for 2D/3D cell cultures. Tumor and stromal cell growth in live cultures
was simultaneously monitored using their distinct ﬂuorescent protein markers until stationary phase was
reached. Here is a quick guide how to normalize the data, and establish corresponding growth curves. For
tissue slice culture the need to cultivate tissue slices on ﬁlter support, and the thickness of the slices
rendered it impractical to apply a similar strategy to follow tumor cell behavior in real-time.
Tumor Media Constituents
MCF7 DMEM (Sigma) supplemented with glutamine (2 mM; Gibco), penicillin (100 Uml−1; Gibco), streptomycin (100 μgml−1; Gibco)
and 10% foetal bovine serum (FBS; Gibco).
NCI H1437, PDX 1,647 RPMI −1,640 (Biochrom) supplemented with glutamine (2 mM; Gibco), penicillin (100 Uml−1; Gibco), streptomycin (100
μgml−1; Gibco) and 10% foetal bovine serum (FBS; Gibco)
PC295, PC310, PC346C DMEM/F12 medium (Lonza, Belgium) supplemented with 2% FBS (Gibco), 1% insulin-transferrin-selenium (Gibco BRL), 0.01%
bovine serum albumin (Boehringer Mannheim), 10 ngml−1 epidermal growth factor (Sigma-Aldrich), penicillin/streptomycin
antibiotics (100 Uml−1 penicillin, 100 μgml−1 streptomycin; Lonza) plus the following additions: 100 ngml−1 ﬁbronectin (Harbor
Bio-Products), 20 μgml−1 fetuin, 50 ngml−1 cholera toxin, 0.1 mM phosphoethanolamine, 0.6 ngml−1 triiodothyronine, 500
ngml−1 hydrocortisone and 0.1 nM synthetic androgen R1881 (all from Sigma-Aldrich)
KrasG12D;Lkb1ﬂ/ﬂ NSCLC
GEMM tumor
F12 (Gibco) supplemented with 100 Uml−1 penicillin, 100 μgml−1 streptomycin (Gibco), 2 mM glutamax (Gibco), and 22mM
glucose (Sigma-Aldrich) and with 10% fetal bovine serum (Gibco).
Table 4. Media used for tissue slices prepared from xenografts or GEMM tumor models.
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Step 1: For both ﬂuorescence spectra, calculate the means of the growth medium/matrix controls, which
serve as a background control, and divide or subtract all wells within the plate by this value, as
indicated below in formulas 1 and 2.
Step 2: Calculate the relative growth over time, and then normalize to the reading at day 1.
*Formula 1: (ﬂuorescence_day X/Average ﬂuorescence of Background day X)/(ﬂuorescence day
1/Average ﬂuorescence of Background day 1).
*Formula 2: (ﬂuorescence day X- mean background ﬂuorescence day X)/(ﬂuorescence day 1- mean
background ﬂuorescence day 1).
*Templates to process raw ﬂuorescence intensities to background corrected day 1 normalized values are
provided, and also sample sets of raw data (see raw data EXCEL sheets). The templates are generic and could
be used to process different matrixes, compound treatments and ﬂuorescent wavelength readings.
Step 3: Import normalized values to Graphpad Prism (or similar) for visualization of the growth curves.
Step 4: Several statistical tests/procedures were used for an analysis of the growth curves.
*Test for normality using the Shapiro-Wilks test.
*Non-parametric analyzes were done with the Mann-Whitney-U-Test, parametric with the t-test. Multiple
groups were compared using a one-way ANOVA using the Tukey post-hoc test. Signiﬁcances are depicted
as n.s.: not signiﬁcant, *Po0.05, * *Po0.01, * * *Po0.001.
EXCEL ﬁles containing exemplary datasets for 2D and 3D models have been uploaded to Figshare (see
data records section).
Cell proliferation staining of 2D and 3D matrix embedded cell cultures. Cells were stained with
Click-iT EdU Alexa Fluor 647 HCS Assay (2 plate kit, Life Technologies C10356) and Hoechst 33342
(Invitrogen, H3570). Growth medium, cell density, cell type variations, and other factors may inﬂuence
labeling. In initial experiments, it is recommended to test a range of EdU concentrations to determine the
optimal concentration for your cell type and experimental conditions. A similar concentration to BrdU is
a good starting concentration for EdU. Whilst BrdU labeling in combination with IHC analysis may be a
workable way forward, the ﬂuorescence-labeled EdU was not used on tissue slices.
Step 1: Prepare stock solutions according to the Click-iT EdU Alexa Fluor 647 HCS Assay manual.
Step 2: Prepare a 2X working solution of EdU (Component A) in medium from the 10 mM stock
solution. Suggested starting concentration is 10 μM. Pre-warm the 20 μM EdU and add an equal
volume of 20 μM EdU solution to medium.
*Use the same medium as in the 2D/3D experiments.
Step 3: Add 100 μl working solution to each well and incubate the cells for 2 h at 37 °C.
*This incubation time should be adjusted according to the proliferation rate of a given cell line.
Step 4: Gently remove the medium from the wells making sure not to damage the 3D matrix. Tilt the
plate slightly and keep the tip of the pipette close to the wall of the well. This will prevent
disturbing the 2D monolayer of cells. Slowly add 150 μl formaldehyde (4%) to the side of each
well and incubate for 30 min at RT.
Step 5: Remove the ﬁxative gently and wash the wells three times with 150 μl of PBS.
*The samples can now safely be stored at 2–6 °C.
Step 6: Remove the wash solution and add 150 μl of 0.1% Triton X-100 in PBS to permeabilize the cells.
Incubate 30 min at RT.
Step 7: Gently remove the Triton X-100 solution from the wells and wash with 150 μl PBS with two
quick washing steps followed by two long washing steps (2 × 15 min). Make sure to remove the
wash solution completely from each well.
Step 8: Perform the EdU detection according to the Click-iT EdU Alexa Fluor 647 HCS Assay manual.
Step 9: Wash each well with 150 μl PBS.
Dilute Hoechst 33348 in PBS (1:1,000) and add 100 μl to each well. Incubate 30 min at RT
wrapped in aluminum foil.
Wash three times with PBS for 10 min. Fill up the wells with PBS.
*At this point the samples can be safely stored at 4 °C for a few weeks until analysis.
Seal the plate with aluminum foil to prevent liquid evaporation and bleaching.
Examine the sample with a suitable microscope.
Image analysis of ﬂuorescence-labeled 3D cell cultures. For the analysis of 3D cultures, a variety of
techniques, both to acquire and analyze images, have been validated and further developed. Up to now,
no image analysis for whole tissue slices has been established yet.
The approaches for the analysis of 3D cultures must be adapted to sample type and microscopes used.
Sample type parameters to be considered are:
- Sample depth: This parameter primarily impacts 3D-embedded cultures. The maximum depth that can
be acquired is typically ca. 1 mm but this is heavily dependent on the microscope settings
(i.e., objectives used).
- Sample density: This takes into consideration the minimal distance between spheroids (and therefore
nuclei). The density in 3D needs to be carefully adjusted to achieve sufﬁcient objects per image (for
statistical analyses), but light transmission from objects above and below should be taken into
www.nature.com/sdata/
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consideration. ‘Light pollution’ and shadowing effects from objects outside of the focal plane, will
impact both the segmentation efﬁciency and the feature values extracted from the micrographs.
- Spheroid size: Larger spheroids (>100 μm) are subject to light attenuation due to light scattering inside
the cell mass, therefore preventing proper imaging of the inner and the deeper parts of the spheroids.
Images of the spheroid cultures may be analyzed using software algorithms developed in MATLAB for
this purpose10. The pipeline to analyze Alginate-BR and matrix embedded (co-) cultures is illustrated in
Fig. 2. For each of the 3D culture methods an example workﬂow, images and analysis parameters are
provided at Figshare, along with a description and an overview table.
3D Floater cultures. Floater cultures contain a single, relatively large and almost spherical spheroid per
well with area sizes of up to 0.5 mm2. Signal attenuation within these large spheroids cannot be addressed
post-imaging, but solutions to improve light penetration proved unsuccessful in our hands5. A pragmatic
alternative is to apply 2D projected spheroid size and shape analyzes. However, analysis of EdU positive
cells, or full 3D analysis appear to be restricted to smaller spheroids for the time being.
2D size and shape analyzes are carried out in an automated fashion using the algorithm provided on
(Data Citation 1) and entitled ‘MATLAB script for the image analysis of 3D image stacks of 3D multi-
cellular spheroid cultures’.
Step 1: Place plate under microscope.
Step 2: Acquire wide-ﬁeld images
*When spheroids are large and analysis of EdU positive cells is not feasible because of signal attenuation,
wide-ﬁeld microscope images are preferred over confocal images. Otherwise, when spheroids are small
(below 200 micron), confocal image stacks should be taken, and analysis protocols should be followed as
described for the alginate BR.
Step 3: Analysis: For 2D size and shape analysis the CellProﬁler pipeline provided on (Data Citation 1)
and entitled ‘Example CellProﬁler pipeline for the image analysis of the breast(lung, prostate)
cancer cell bioreactor cultures’ is used.
3D alginate-BR cultures. These cultures generate spheroids with a maximal area size of 0.01–0.1 mm2,
which, in terms of spheroid sizes, places them between matrix embedded and ﬂoater cultures. The shape
of the spheroids is often irregular, especially when cells leak out of the alginate micro-capsules. The
density of EdU-positive nuclei within these spheroids is relatively high.
For the analysis, alginate-BR samples have non-spherical shapes and the automated segmentation step
based on ellipsoid approximation is not valid. Therefore it is replaced by a manual delineation of the
spheroid contours in 2D (taking the 3D images as a base for examination of the spheroids) and
subsequent detection of the spheroid geometric center in 3D. Afterwards, EdU positive cells are detected
using the 3D spot detection algorithm from10, illustrated in Fig. 3a,b. The cells below the center of the
spheroid are ignored and upper and lower parts of the spheroids are considered equivalent.
Step 1: Collect alginate capsules from the BR and place them in an 8-well plate (μ-Slide 8 well, ibiTreat).
Cover alginate microcapsules with low melting agarose (Sigma) for live image acquisition, or
with ProLong Anti-fade for ﬁxed samples, in order to immobilize the capsules.
Step 2: Acquire 3D image stacks
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Figure 2. Image analysis workﬂow of 3D spheroid tumor cultures. Upper panel, matrix embedded cultures;
lower panel as for alginate-BR cultures. RFP (red): Tumor cells; GFP (green): Stromal ﬁbroblasts; DAPI (blue):
Nuclei; EdU (pink): Proliferating nuclei.
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*Microscope settings see Table 5.
*Images of at least 10 spheroids for the 3 biological replicates should be acquired. Fields with less than 3
spheroids or ﬁelds too close to the border were excluded.
*Image acquisition for size and morphology analysis: Using a lower magniﬁcation objective (10x) allows for
the acquisition of a representative number of spheroids (3 or more) per ﬁeld. The limited imaging depth of
the objective, however, restricts image acquisition to approximately half of the spheroid. Image acquisition
was always initiated from the bottom of the spheroid.
*Image acquisition for proliferation analysis: The 20x magniﬁcation objective allowed a visualization of EdU
positive cells in the inner parts of the spheroids while still covering whole spheroids in the xy-plane. The
z-step is set to 1 μm, to resolve the EdU positive cells. To allow correlation-studies between size, shape and
proliferation, all spheroids of the ﬁeld acquired from the lower magniﬁcation (10x) were also imaged with
the 20x as sub-images.
Step 3: Analysis: Size and 2D shape analysis may be analyzed by the automated analysis algorithm and
parameters provided on (Data Citation 1) and entitled 'MATLAB script for the image analysis of
3D image stacks of 3D multi-cellular spheroid cultures'. For the analysis of EdU positive cells, the
algorithm input allows manually outlined spheroids and z-location parameters as ImageJ ROI’s.
*Spheroid size determination: Due to the above-described restrictions of imaging depth, spheroid areas
rather than volumes should be quantiﬁed. It should be noted, however, that area or volume do not
necessarily reﬂect cell growth or death, since cell density may vary considerably between spheroids. Also the
addition of stromal cells may affect spheroid compactness e.g., via stiffness and various deposits. EdU or
some cell death markers may be required if cell proliferation or death is an important readout.
3D matrix-embedded cell cultures. These cultures contain many, relatively small homogenously
distributed spheroids with area sizes of up to 0.005 mm2. When imaged at the stationary phase, as in our
setting, the number of EdU-positive cells is relatively low. The shape of the spheroids depends on the
matrix: Matrigel results in nearly spherical spheroids, whereas collagen induces more irregular shapes.
RFP 
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EdU 
100 
EdU 
GFP 
DAPI RFP 
EdU 
Matrix embedded Alginate - BR 
EdU 
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Figure 3. Examples for the image processing workﬂow. (a,b) A ﬂuorescent spheroid from an alginate-BR
culture with (b) the detection of EdU positive cell illustrated, where red circles indicate positive cells. (c) A
small subset of an image-stack of a matrix (Matrigel, DMSO) embedded 3D spheroid culture, where in panel
(d) the detection of EdU positive cells is shown as circles within spheroids (red circles outside the spheroid
originate from proliferating ﬁbroblasts). The spheroids themselves are approximated by ellipsoids and shown in
color. In (e,f) the top and side view of the segmentation contours are shown to illustrate the ellipsoid
approximation. Spheroids only visible in (f) but not in (e) are originating from (x,y)-coordinates outside the
subset of the xy-plane. RFP (red): Tumor cells; GFP (green): Stromal ﬁbroblasts; DAPI (blue): Nuclei; EdU
(pink): Proliferating nuclei.
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The same holds true for combined matrices with different ratios of collagen versus Matrigel (see also
‘Matrix concentration’). Since the spheroids are distributed in three dimensions, the range along the
z-direction should be extended as far as possible. All samples should be quality checked for even
distribution of spheroids along the z-axis (see validation part), cells growing on the plastic surface, torn/
folded ECM because of ﬁbroblast-induced collagen shrinkage or other issues.
3D matrix embedded cell cultures were analyzed using an ellipsoid approximation for the spheroids as
described10. For samples consisting of very invasive spheroid types (e.g., in collagen), spheroids cannot be
approximated by ellipsoids and a less-deﬁned spheroid contour is used instead. Fig. 3c–f illustrates the
results for the ellipsoid approximation of a 3D image stack taken from a homogenously distributed assay
of prostate cancer cells.
Step 1: Place plate under microscope.
Step 2: Acquire 3D image stacks:
*For examples of the microscope set-up, see Table 5.
*A compromise needs to be found between resolution, coverage in z-axis, and scan speed/memory usage:
We would recommend the use of a 10x magniﬁcation objective, which reaches a depth of about 1 mm along
the z-axis, with a z-step of 10 μm. This roughly corresponds to the diameter of a nucleus, and thus avoids
missing the EdU signal, while optimizing scan-speed. If spheroids contain a large percentage of positive
cells, objectives or microscopy set-ups with a smaller axial resolution would have to be used.
*QC checks: Homogeneous distribution, density of the spheroids in the culture (see also technical
validation), no cell growth on the bottom. Morphology of the spheroids and consequences for the analysis
algorithms (e.g., is the assumption that spheroids are round or oval correct?) Shrinkage or folding/tearing of
the matrix.
Fluorescence Microscope settings
Platform Instrument Objective (NA) Fluoro-phore Filters
Excitation [nm] Emission [nm]
3D ﬂoaters Zeiss (LSM700) 10x EC PLAN NEOFLUAR M27 (0.3) dTomato BP 546/12 BP 575–640
GFP BP 450–490 BP 515–565
Hoechst 365 BP 445/50
EdU BP 640/30 BP 690/50
Zeiss (LSM510 META Multiphoton) 10x Plan Apochromat (0.45) tRFP 561 BP 565–615
GFP 488 BP 500–530
Hoechst 405 BP 390–465
EdU 640 BP 650–710
ZEISS (Axiovert 200M) 10x A-Plan (0.25) dTomato BP 546/12 BP 575–640
GFP BP 475/40 BP 530/50
3D BR Andor (Revolution WD Spinning Disk) 10x Plan Fluor (0.3) 20x Plan Fluor (0.75) dTomato 561 (DPSS) BP 595/50
GFP 488 (OPSL CW) BP 525/50
Hoechst 405 BP 460/50
EdU 640 (DPSS) BP 685/40
3D matrix Zeiss (LSM700) 10x EC PLAN NEOFLUAR M27 (0.3) dTomato BP 546/12 BP 575–640
GFP BP 450–490 BP 515–565
Hoechst 365 BP 445/50
EdU BP 640/30 BP 690/50
Yokogawa (CV 7,000 Spinning Disk) 10x UPLSAPO (0.4) dTomato 561 BP 600/37
GFP 488 BP 522/35
Hoechst 405 BP 447/45
EdU 640 BP 676/29
Zeiss (Axiovert 200M) 10x A-Plan (0.25) tRFP BP 546/12 BP 575–640
GFP BP 450–490 BP 515–565
Hoechst 365 BP 445/50
EdU BP 640/30 BP 690/50
Table 5. Microscopes, Objectives, and ﬁlters for imaging. NA—Numerical aperture; BP—Band pass;
DPSS—Diode-pumped solid-state lasers; OPSL CW—Optically pumped semiconductor lasers continuous
wave. Taken, with modiﬁcations, from ref. 5.
www.nature.com/sdata/
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Step 3: Analysis: Spheroids may be analyzed using the automated analysis algorithm and parameters
provided on (Data Citation 1) and entitled 'MATLAB script for the image analysis of 3D image
stacks of 3D multi-cellular spheroid cultures'.
*Input parameters for the automated spheroid segmentation have to be adjusted according to the expected
spheroid shape—spherical to invasive morphology (see also the images on (Data Citation 1) where example
images for each of this types are provided).
*Spheroid homogeneity and density may be assessed post-analysis.
Formalin-ﬁxed parafﬁn-embedded (FFPE) 3D, tissue slice cultures. Being able to generate parafﬁn
embedded blocks of 3D cultures and tissue slices is essential for the analysis of the structural and
functional complexity of a given model, particularly its heterogeneity. The spatial conﬁguration of cells, as
well as their interactions with neighboring cells and the extracellular matrix are preserved. Moreover,
parafﬁn blocks may be stored for long periods of time, remaining accessible and allowing multiple
researchers to address their model-speciﬁc questions. Within the PREDECT project, protocols to
process complex 3D cultures and tissue slices for parafﬁn embedding were established, allowing for a
cross-comparison of the models using TMAs (tissue microarrays). These methods were brieﬂy described
in the original manuscripts5,9; the individual steps are described and illustrated in more detail below and
in Fig. 4.
3D ﬂoater cultures. The protocol starts from ﬂoaters cultivated in U-bottom 96-well (Corning #4520)
or 384-well plates (Corning, # 3830).
Step 1: Collect ca. 100 spheroids into a Falcon tube.
Step 2: When all spheroids have settled to the bottom of the tube, aspirate medium and wash the
spheroids in PBS twice, taking great care not to lose the spheroids, before ﬁxing for 20 min in 5
ml of 4% paraformaldehyde. Wash again twice in PBS, stain for 10 s in a 1:1 solution of Mayer’s
Hematoxilyn:PBS and wash another three times in PBS.
Step 3: Heat a tube of solid HistoGel (ThermoScientiﬁc, HG-4000-012) in a dry block heater
(ThermoScientiﬁc, 2050Q) to 60 °C. Resuspend the spheroids in 1 ml PBS and transfer them to a
1.5 ml tube. Remove the supernatant carefully, then add 30 μl of HistoGel to the spheroids, and
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Figure 4. Flow diagram illustrating the steps of processing 3D culture models. Collagen or collagen/
Matrigel embedded 3D cultures, ﬂoaters, alginate-BR, and tissue slices.
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mix the solution in order to homogenously distribute the spheroids within the HistoGel. Let the
HistoGel set by cooling the tube to 4 °C for 15 min.
Step 4–6: Remove the slide of the 8-chamber, wrap the now solid plug into histo-wrap paper and place it
into a tissue cassette for automatic processing.
*If shrinkage of the sample during dehydration is an issue, the samples may be processed manually,
following the same protocol as for the automatic processor, i.e., 20 min in 50% isopropanol, twice 20 min
in 70% isopropanol, twice 30 min in 95% isopropanol and three times 30 min in 100% isopropanol at 37 °
C. Also for the manual protocol, washing with parafﬁn solvent followed in the tissue processor at 60 °C,
three times 30 min, with vacuum and pressure off.
Finally, embed the samples in parafﬁn wax.
3D alginate-BR cultures. The protocol starts with a stirred tank culture of alginate microencapsulated
spheroids, with and without ﬁbroblasts.
Step 1: Collect the microencapsulated spheroids into a Falcon tube.
Step 2: Let the microcapsules settle to the bottom of the tube, then aspirate the medium and wash the
spheroids carefully with PBS twice, taking great care not to lose the spheroids. Fix them for
20 min in 5 ml of 4% paraformaldehyde/4% sucrose solution. Wash again twice in PBS, stain for
10 s in a 1:1 solution of Mayer’s Hematoxilyn:PBS and wash another three times in PBS.
Step 3: Boil a 1% (w/v) agarose (Lonza) solution to dissolve the agarose, then let the agarose temperature
cool down to 50 °C (in a water bath or a thermomixer). Resuspend the microcapsules in 1 ml PBS
then transfer them to a 1.5 ml tube. Remove the supernatant carefully, resuspend the
microcapsules with 50 μl of the agarose solution, and mix well in order to homogenously
distribute the spheroids within the gel. Let the agarose cool down on ice for 5 min.
Step 4–6: As described above.
3D matrix-embedded cultures. This procedure does not work with pure Matrigel since the ﬁxation
step dissolves the gel.
Multiple samples may be processed at the same time.
The protocol starts with a 96-well plate of matrix-embedded cultures.
Step 1: Carefully remove the medium supernatant, and ﬁx the samples by ﬁlling the wells with 4%
paraformaldehyde. After 20 min at RT, wash the wells carefully with PBS, and stain the samples
with a 1:1 solution of Mayer’s Hematoxilyn:PBS for 10 s and wash again with PBS.
*The latter step enables an easy localization of the spheroids within the parafﬁn block later.
Step 2: Extract the samples from the well using a lab spatula.
Step 3: In order to maintain the integrity of the fragile 3D cultures throughout the remaining embedding
protocol, the samples should be pre-embedded in HistoGel (ThermoScientiﬁc, HG-4000-012).
*Optimal results were obtained when three 3D spheroid-matrix plugs (a triplicate) were combined.
Heat a tube of solid HistoGel in a dry block heater (ThermoScientiﬁc, 2050Q) to 60 °C, and pre-
coat a chamber of an 8-chamber slide (Labtek #155411) with 100 μl of the now liquid HistoGel.
Place the triplicate spheroid-matrix plug on top of the pre-coating and overlaid it another 300 μl
of HistoGel. Then transfer the 8-chamber slide to 4 °C for 15 min for the Histogel to set.
Step 4–6: As described above.
Tissue slice cultures
Step 1: Remove tissue slice carefully from the organotypic support using a spatula and probe. Millipore
supports are non-adherent, allowing slices to be removed easily.
*Not all ﬁlter supports are non-adherent—if FFPE processing is planned make sure to choose a non-
adherent support or an adherent support that can be processed with the tissue.
Step 2: To ensure correct orientation of the slice when analysing samples via IHC, paint the air-side of
the slice with marking ink for pathology.
Step 3: Place slice into a biopsy capsule (e.g., CellPath, EBE-0201-02A), a biopsy bag, or two layer of
ﬁlter papers (e.g., R. Langenbrinck,Labor- und Medizintechnik) and place in normal histology
cassette to ensure the slice remains ﬂat during processing.
Step 4: Fix the slices in formalin for a minimum of 24 h prior to parafﬁn embedding,
*Normal processing programs can be used but it is also possible to process slices on a rapid 2.5 h program
used for biopsies.
Step 5: Slices can be embedded horizontally or vertically to capture any changes in biomarker expression
*See validation section for a discussion about the impact of the slice orientation on the experimental
readout.
Tissue microarray construction. All cell culture FFPE blocks were collected and archived centrally at
the Institute for Molecular Medicine Finland (FIMM) as tissue microarrays (TMA)11. Examples for
TMAs and cores are shown in Fig. 5.
Step 1: Punch a single core from the FFPE blocks using a semi-automatic punching device (MiniCore,
Mitogen, UK).
www.nature.com/sdata/
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*A 1mm core size was used for cell culture samples with high cell density (2D, ﬂoaters and bioreactor
cultures). For matrix-embedded 3D cell cultures with low cell density, a core size of 5 mm was selected
(Fig. 6).
*If samples are very heterogeneous, and the blocks allow for it, more than 1 punch per sample should be
included in the TMA.
*Use an asymmetric design for the array in order to be able to track sample locations
Step 2: Cut 3.5 μm sections on Superfrost objective glasses (Kindler O Gmbh, Germany) using, e.g., a
Microm 355S microtome (Thermo Scientiﬁc, Waltham, MA). Dry slides on heating block or
over-night at 37 °C. Store slides at −20 °C for long-term.
Immunohistochemistry.
Step 1: If multiple IHC markers are to be stained, it is advisable to cut all TMA sections in one cutting
session to obtain only consecutive sections. Adhere parafﬁn sections to glass slides overnight at
37 °C.
*Slides may be stored at −20 °C for at least 6 months.
Step 2: Deparafﬁnize sections:
Three times 5 min in Xylene (Fluka/FFChemicals)
Three times 1 min in 99.8% EtOH (Altia)
Twice 1 min in 96% EtOH
Once 1min in 70% EtOH
Once 1min in water
Step 3#: Induce antigen retrieval at 99 °C, for 20 min in 10 mM Tris-HCl (Sigma)+1 mM EDTA (Sigma)
*Buffer stable for two weeks or 40 slides
Step 4#: Wash for 3 min in 1X PBS (Biotop)+0.05% Tween20 (Fisher Scientiﬁc)
Step 5*: Incubate for 15 min in 0.9% H2O2 solution (Fluka) to block peroxidase activity
Step 6*: Wash in 1X PBS+0.05% Tween20.
Step 7*: Incubate for 15 min in 1X PBS+10% GNS (Millipore) to block non-speciﬁc binding
*Air blow the blocking solution off the slide before primary antibody (do not wash!). If manual protocol is
used, pour/tap the blocking solution off the slide.
Figure 5. Tissue microarrays and examples of single cores. 5 mm core size for MCF7 as embedded 3D
culture (a) and 1 mm core size for H1437 cell line cultured in alginate-BR (b). Scale bar 100 μm.
www.nature.com/sdata/
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Step 8*: Dilute primary antibody in 1X PBS+10% normal goat serum (NGS; Millipore).
Incubate for 90 min (or as applicable) at RT
Step 9*: Wash twice in 1X PBS+0.05% Tween20
Step 10*: Dilute secondary antibody (Immunologic) in 1X PBS+10% GNS
Incubate for 30 min at RT
Step 11*: Wash twice in 1X PBS+0.05% Tween20
Step 12*: Stain with DAB (3,3′-Diaminobenzidine; Immunologic) according to manufacturer’s
instructions
Step 13*: Rinse with water to stop DAB stain reaction
Step 14: Counterstain 1 min in 25% Mayers Hematoxylin (DAKO) in H2O
Step 15: Rinse for 5 min in running cold tap water
*Avoid direct exposure of the slides to the running water
Step 16: Dehydrate
Once 1 min in 70% EtOH
Twice 1 min in 96% EtOH
Three times 1 min in 99.8% EtOH
Three times 1 min in Xylene
Step 17: Mount using Pertex-mountant (HistoLab), leave to air dry
#in a PT Module (Thermo Scientiﬁc): Steps 3–4
*in a Lab Vision Autostainer 480S (Thermo Scientiﬁc): Steps 5–13
Hematoxylin and Eosin staining (H&E).
Step 1: Deparafﬁnize sections:
Three times 5 min in Xylene (Fluka/FFChemicals)
Three times 1 min in 99.8% EtOH (Altia)
Twice 1 min in 96% EtOH
Once 1 min in 70% EtOH
Once 1 min in water
Step 2: Incubate 10 min in Mayer´s Hematoxylin (undiluted)
Step 3: Flush for 5 min in running cold tap water water (avoid direct exposure of the slides to the
running water)
Step 4: Differentiate by dipping the slides twice in 70% EtOH+1% HCl
Step 5: Flush in running cold tap water, 5 min
Step 6: Incubate in 0.5% Eosin, 30 s
Step 7: Dehydrate
Twice 1 min in 96% EtOH
Three times 1 min in 99.8% EtOH
Three times 1 min in Xylene
Step 8: Mount using Pertex-mountant, leave to air dry
Data Records
Generation of growth curves for 2D/3D cultures
Examples for growth curves of 2D (LNCaP (RFP)/WPMY1 (GFP) OR CAF (GFP): RawData_2D_Pros-
tate_SD.xls), 3D ﬂoaters (LNCaP (RFP)/WPMY1 (GFP) OR CAF (GFP): RawData_Floaters_Prosta-
te_SD.xls), 3D BR (H1437 (RFP)/NF (GFP) OR CAF (GFP) AND MCF7 (GFP)/NDF (RFP):
RawData_BR Lung_Breast_SD.xls), and 3D matrix-embedded cultures (MCF7 (GFP)/NDF (RFP):
RawData_3Dmatrix_Breast_SD.xls; LNCaP (RFP)/WPMY1 (GFP) OR CAF (GFP): RawData_3Dma-
trix_Prostate_SD.xls; H1437 (RFP)/NF (GFP) OR CAF (GFP): RawData_3Dmatrix_Lung_SD.xls) have
been uploaded to (Data Citation 1). The examples are as described in Ref. 5.
Image analysis of ﬂuorescence-labeled 3D cultures
The following section describes the 3D analysis procedures used for the 3D analysis of the 3D ﬂuorescent
spheroid cultures used in Ref. 5. The main tools used for the analysis are:
- FIJI (ImageJ): Used to outline manual ROI's of spheroids (using the RoiManager),
- MATLAB: 3D spheroid segmentation, shape analysis and EdU positive cell detection,
- CellProﬁler: 2D spheroid detection and 2D shape analysis,
- R & RStudio: Data analysis of the output of the above two.
We also used ZEN 2.0 LIGHT for the conversion of czi formatted raw image data to tif-stacks.
Below we try to provide a workﬂow for each of the different ﬂuorescent 3D cultures. The raw image(s)
have been uploaded to (Data Citation 1), and the metadata corresponding to the ﬁle names of the images
is documented in the samples overview table ‘sample_overview_table.xlsx’ which we will refer further to
as the ‘samples overview table’. The raw images are either 3D multi-channel stacks taken with a confocal
microscope, or 2D (multi-)channel wideﬁeld images. The image analysis of the 3D confocal stacks is
mostly done using the algorithm provided at https://github.com/mbarbie1/ellipsoids-analysis-paper,
www.nature.com/sdata/
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while 2D wideﬁeld images are analyzed using CellProﬁler pipelines. Both are uploaded to
(Data Citation 1) as ‘ellipsoids-analysis-paper-master.zip’ (entitled: ‘MATLAB script for the image
analysis of 3D image stacks of 3D multi-cellular spheroid cultures’) and ‘Wideﬁeld_bioreactor_breast
(lung, prostate)_gfp.cpproj’ (entitled: 'Example CellProﬁler pipeline for the image analysis of the prostate
cancer cell ﬂoater cultures').
The data output from the MATLAB script ‘ellipsoids-analysis-paper-master.zip’ contains 3 tables:
msrSpheroids.csv, msrSpots.csv and summary.csv, and is described in the ﬁle ‘output_data_ellipsoid_a-
nalysis_description.xlsx’ which is also uploaded to (Data Citation 1) and entitled: ‘MATLAB script:
overview of the output’. To use the CellProﬁler pipelines, the location of the image ﬁles inside the
CellProﬁler pipeline should be adapted to one's own needs as well as the pattern to extract the image
metadata from the ﬁles (this can be done in the input modules ‘Images’ and ‘Metadata’). The default
output folder in CellProﬁler is used to save the output, but this can also be adjusted in the SaveImages
and ExportToSpreadSheet modules if desirable. The input images are assumed to be RGB images, from
which then the different channels are extracted, if the separate channels are available, it is probably better
to use those and to adapt the pipeline accordingly.
Bioreactor samples. Samples originating from the bioreactor, referred to as BR-alginate in the samples
overview table, were imaged both with wideﬁeld and confocal microscopy. The workﬂow for both is
described below.
Wideﬁeld images. The wideﬁeld images are analyzed using the CellProﬁler pipeline in ‘Wide-
ﬁeld_bioreactor_lung_rfp.cpproj’ and ‘Wideﬁeld_bioreactor_breast_gfp.cpproj’, which are entitled:
‘Example CellProﬁler pipeline for the image analysis of the breast(Iung) cancer cell bioreactor cultures’.
As explained in the introduction the CellProﬁler pipelines should be adapted to one's own needs.
Confocal stack images. For the confocal stack images ﬁrst the 3D spheroids in the images can be
manually outlined using the RoiManager of FIJI. These ROI’s can then be provided to the analysis script
in the MATLAB procedure at https://github.com/mbarbie1/ellipsoids-analysis-paper. ROI’s must only be
provided when the automated spheroid detection cannot discern different spheroids, which can happen
when the imaging depth is less than the spheroid size.
Floater samples. The ﬂoaters are imaged using wideﬁeld microscopy, and can be analyzed by simple
CellProﬁler pipelines provided in ‘Wideﬁeld_ﬂoater_breast_gfp.cpproj’, ‘Wideﬁeld_ﬂoater_prostate_rfp.
cpproj’, and ‘Wideﬁeld_ﬂoater_lung_rfp.cpproj’, which are entitled: ‘Example CellProﬁler pipeline for the
image analysis of the breast(Iung, prostate) cancer cell ﬂoater cultures’. As explained in the introduction
the CellProﬁler pipelines should be adapted to one's own needs.
Treated ﬂoater samples tended to be extremely fragile and could not be processed for imaging.
Matrix-embedded samples. For the confocal stack images of matrix embedded cultures the analysis
script in the MATLAB procedure in ‘ellipsoids-analysis-paper-master.zip’ can be used without manually
outlining the spheroids.
The examples uploaded to (Data Citation 1) are as described in Ref. 5. Due to their size, only a selection of
the embedded prostate imaging stacks has been uploaded.
Technical Validation
Tracking cell growth via RFP/GFP ﬂuorescence
Tumor and stromal cell lines were transduced with lentiviral constructs, encoding either red ﬂuorescent
protein (RFP) or green ﬂuorescent protein (GFP). This reporter system, if truly reﬂecting the number and
viability of cells in a culture, enables live-cell monitoring of tumor and stromal cell growth in parallel in
the same culture. However, as described below, the correlation with cell growth should be established for
every system using (an) independent modalit(y/ies).
GFP and RFP signals do not overlap
In order to make sure the ﬂuorescence proteins were speciﬁc for tumor and stromal cells, respectively,
increasing numbers of cells were plated in 2D, and the ﬂuorescence signal measured using ﬁlter sets for
either ﬂuorescent protein.
No bleed-through was observed from one ﬂuorescence channel into the other, and a positive
correlation between RFP/GFP signals with cell numbers could be demonstrated (Fig. 6a). Similar
correlations were observed when increasing number of cells were embedded into 3D matrix and
ﬂuorescence was measured the next day (data not shown).
Fluorescent- and metabolism-based growth assays correlate
In order to ensure that the ﬂuorescence signal detected from GFP or RFP reﬂected actual cell growth, Cell
Titer Glo (Promega), which is based on a measurement of the cells’ ATP content, was chosen as an
alternative means to quantify the increase of cell mass in 3D cultures. LNCaP cells were cultivated as
ﬂoaters, and growth of the cultures was measured in parallel at the same time points.
www.nature.com/sdata/
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Growth could readily be measured with either assay. Both measurements showed similar growth
characteristics, conﬁrming that the ﬂuorescent protein-based measurement was a reliable method for
live-cell monitoring of the growth of 3D cultures (Fig. 6b).
As a second standard cell viability assay, Alamar blue, which is converted to a red-ﬂuorescent dye,
resoruﬁn, in cells with intact mitochondria, was compared to RFP ﬂuorescence for its potential to detect
Paclitaxel-induced cell killing. LNCaP cells were embedded into matrix and treated with increasing doses
of the cytotoxic agent Paclitaxel. After 24 h, the RFP ﬂuorescence signal was measured, before Alamar
blue was added, and, 3 h later, the ﬂuorescence of the generated resoruﬁn was detected.
The dose response curves of both measurements showed similar trends, indicating that the ﬂuorescent
reporter signal-based measurement of cell viability was comparable to a standard cell viability assay
(Supplementary Fig. S3). Thus, the reporter signal-based measurement should be a reliable method to
establish relative cytotoxicity of agents in drug treatment studies.
As a third alternative assay, Picogreen (Quant-iT PicoGreen dsDNA Assay; Kit P7589; Thermo Fisher
Scientiﬁc) was tested in the Alginate-BR system. Picogreen is based on the ﬂuorescent quantiﬁcation of a
probe that intercalates into dsDNA. This assay was chosen as a validation method since the DNA
concentration is independent of the differentiation state and identity of a cell, contrary to total protein
concentration.
1 ml of culture suspension was collected every 3–4 days, in duplicates, and the DNA was quantiﬁed
using the Picogreen protocol, according to the manufacturer’s instructions. Fluorescence measurements
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Figure 6. RFP and GFP signals may be used as a proxy to monitor cell growth in 2D and 3D. (a) tRFP and
eGFP signals correlated with the cell numbers of LNCaP and CAF cells, respectively, when grown in 2D (left
panel) or 3D cultures (right panel). LNCaP and CAF cells were seeded at different cell densities (N= 3–6). One
day after seeding the cells, the ﬂuorescent signal was measured at the bottom of the well by spectrophotometer.
No bleed-through was observed when tRFP-labeled LNCaP were measured in the green channel (grey line with
circles), or eGFP-labeled CAF cells in the red channel (grey line with triangles). Error bars are standard
deviation from the mean (N= 3–6). (b) Comparison of ﬂuorescent protein- and Cell titer Glow assay-based
measurement of LNCaP 3D spheroid growth. 3D models were set up and growth of LNCaP tumor cells was
monitored via RFP ﬂuorescence intensity (left panel/left y-axis) or the cell titer glow assay (left panel/right
y-axis), which measures intracellular ATP content, and hence requires cell lysis. Fold increase of ﬂuorescence
units (left panel/left y-axis) and luminescence units (left panel/right y-axis) relative to day 1 are shown over the
course of 15 days. Error bars represent the standard deviation from mean values (N= 3). The right panel shows
the excellent correlation between the two measurements (r2= 0.9566; linear regression), suggesting that
ﬂuorescent protein-based measurement, which does not require cell lysis, is a reliable method for monitoring
3D culture growth.
www.nature.com/sdata/
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were performed in the ﬂuorescence reader (Table 5). Results are presented as a fold increase compared to
day 1 (Supplementary Fig. S4).
The ﬂuorescent protein-based measurement has several advantages over the classical metabolism
based assays, since it allows, (1), for real-time growth monitoring of the spheroids and, (2), in co-cultures,
for parallel measurements of tumor and, e.g., stromal cells. The only requirement is that the cells’
ﬂuorescence be bright enough for detection by the spectro-ﬂuorometer.
3D matrix embedded culture set-up
Conditions for 3D embedding have to be optimized for any mono- or co-culture experiment. This section
describes the optimization process for the PREDECT 3D embedded cultures. Several parameters, such as
cell numbers, ratios, and matrix density, were tested.
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Figure 7. Cell density titration in BME and collagen. LNCaP tumor cells were seeded as triplicates in
Matrigel (7 mgml−1 (BME/Trevigen); left panel) or collagen (right panel) at densities 1 × 104, 1 × 105, and
1 × 106 cells per well. Growth of LNCaP tumor cells was monitored via RFP ﬂuorescence, shown as mean
absolute ﬂuorescent units with error bars marking the standard deviation (N= 3). Seeding 1 × 104 cells resulted
in exponential growth in both matrices (blue), 1 × 105 cells remained in equilibrium (green) while 1 × 106 cells
appeared too dense for growth or cell survival to be supported (red).
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Figure 8. Effect of cell density on spheroid morphology. LNCaP tumor spheroids seeded at 10,000 (a) or
100,000 cells (b) in Matrigel/BME (top) and collagen (bottom). Maximum projection images on day 14 (left
panel) and stained spheroids on day 22 (right panel). EdU (red proliferating cells), NucView (green apoptotic
cells), and Hoechst (blue nuclei). Note that larger spheroids have an apoptotic core and more proliferating cells
at the outer layers.
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Cell density
The ﬁrst step was to optimize the number of tumor cells to be seeded in 90 μl matrix per 96 well. As
shown in Fig. 7, seeding 10,000 tumor cells per well resulted in an exponential growth in both basement
membrane extract (BME, Trevigen) and collagen I (BD Bioscience), reaching a plateau after
approximately 14 days. When increasing the number to 100,000 tumor cells, the cell density remained
constant over the course of the experiment. When increased to 1,000,000 cells, the ﬂuorescence signal
decreased over time, indicating that this number of cells could not be supported by the matrices. Thus a
starting point for our 3D cultures would be 10,000 cells per 90 μl matrix.
The above growth curves suggested that both the 10,000 and 100,000 cell cultures are viable but
maximum projection images at day 14 revealed morphological differences. A higher cell density appears
to result in smaller spheroids in both BME and collagen (Fig. 8a). Additional proliferation and apoptosis
staining on day 22 revealed that both the larger and smaller spheroids have proliferating cells after long
term culturing but only the larger ones have an apoptotic core and more proliferating cells on the outer
layer of the spheroids (Fig. 8b). Seeding 10,000 cells also resulted in more round shaped spheroids
compared to the high-density culture.
Matrix concentration. In order to determine the optimal Matrigel (Corning) concentration to sustain
homogenous 3D growth of tumor cells, a Phaedra analysis as described by Cornelissen and colleagues12
was performed for a range of Matrigel concentrations from 1–8 mgml−1.
The analysis showed that Matrigel concentrations higher than 3 mgml−1 resulted in a homogenous
distribution of 3D spheroids throughout the gel, whereas lower concentration couldn’t prevent the
spheroids from sinking towards bottom of the wells, allowing for 2D growth (Fig. 9). Maximum
projection analysis also showed that the 3D spheroids lose their round shape in Matrigel concentrations
below 4mgml−1 (Fig. 9). Based on these results and with respect to the cost effective use of Matrigel, the
concentration of 4 mgml−1 was chosen as appropriate and used in further experiments.
Tumor:Stroma cell ratio. In order to determine the optimal ratio of tumor to stroma cells for 3D
embedded cultures, a series of ratios of the two cell types was tested for the growth stimulating effect of
the stromal cells on the tumor cells in collagen (here: HDF human dermal ﬁbroblasts and MCF7 breast
cancer cells), and the collagen contracting activity of the HDFs. The latter interferes with most
downstream analyzes, and should therefore be avoided by limiting the number of stromal cells in a co-
culture model.
While a ratio of tumor:stroma cells of 1:1 clearly gave the most pronounced growth stimulatory effect
on the MCF7, it also resulted in a strong contraction of the collagen gel (Supplementary Fig. 5). All other
1 mg/ml 2 mg/ml 3 mg/ml 4 mg/ml 
5 mg/ml 6 mg/ml 7 mg/ml 8 mg/ml 
Figure 9. Phaedra analysis of 3D embedded LNCaP tumor cells in Matrigel. LNCaP cells were embedded in
1–8 mgml−1 Matrigel. Note that at matrix concentrations of 3 mgml−1 or less, cells tend sink to the bottom of
the well. Note that at concentrations of 4 mgml−1 or higher, an even distribution of the spheroids in the matrix
is observed. Also, spheroids in 4 mgml−1 Matrigel and higher appear to be more rounded.
www.nature.com/sdata/
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ratios gave a similar stimulation of MCF7 growth, except for a ratio of 20:1, and only a 2:1 ratio resulted
in a similar contraction of the collagen gel. Thus tumor:stroma cell ratios between 3:1 and 10:1 are
functional without affecting the collagen matrix.
FFPE embedding
Good quality H&E and IHC images from histological sections of a TMA (see ref. 5) are proof of the
quality of the FFPE procedure described here (modiﬁed from refs 13,14).
3D culture models
We successfully processed tiny, viscous, and fragile 3D cultures, preserving structural complexity and
morphological features, except for Matrigel embedded 3D cultures. The structure of 3D complex cultures
grown in Matrigel was lost while ﬁxed in 4% paraformaldehyde (not shown). We managed to partly
prevent depolymerization of Matrigel by addition of 0.25% glutaraldehyde (Supplementary Fig. S6). The
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Figure 10. Loco-regional changes in IHC biomarkers in tumor slices cultivated under optimal conditions
(ﬁlter support, atmospheric oxygen). (a) Lung GEMM tumor slices, horizontally embedded, were found to
contain large areas of necrosis at the ﬁlter interface of the slice. Scale bars represent 1,000 μm. (b) AR staining
revealed that AR positive cells were in abundance at the air interface in prostate PDX tumor slices and were
greatly reduced at the ﬁlter interface. Scale bars represent 1,250 μm. (c) H&E stained sections of vertically
embedded MCF7 CDX tumor tissue slices. Images show differences in tissue morphology dependent on their
proximity to the air interface of the slice. (i) Arrows: Areas of necrosis; arrowheads, vacuolated regions (ii)
Arrow: Mitotic ﬁgure. (d) H&E stained section of vertically embedded H1437 CDX tumor slice, showing
similar morphology to that observed in MCF7 tumor slices. (e) Immunohistochemical staining of HIF1α in
MCF7 tumor slices showed an accumulation of nuclear protein at the ﬁlter interface of the slice, and
immunohistochemical staining of ER, which showed a reduction in staining at the ﬁlter interface. Unless
speciﬁed, all scale bars represent 100 μm. Taken from ref. 9.
www.nature.com/sdata/
SCIENTIFIC DATA | 4:170170 | DOI: 10.1038/sdata.2017.170 20
increased aldehyde concentration which appears to provide Matrigel preservation may, however, interfere
with antibody binding15. Therefore, Matrigel embedded 3D cultures were not included in
immunohistochemical analysis.
Tissue slice models
Tissue slices represent biologically complex cell-matrix structures of ﬁnite depth. Hence, to evaluate the
tissue slice composition and biomarker expression across the slice, 10% neutral buffered formalin-ﬁxed
slices can either be embedded in parafﬁn in vertical or horizontal orientation (Supplementary Fig. S7).
The choice of orientation depends on the experimental question; the horizontal slice surface analysis
allows a larger area of analysis across a single tumor lesion, while the vertical orientation permits analysis
of the slice interior, to study potential culture-induced biomarker gradients across the depth of the slice
(see next section for further details).
Validation of tissue slice culture methods
Methods for culturing tumor tissue slices have been described previously, but prior to our publication9,
these methods had not been compared side-by-side, using the same tumor model and different tumor
types. The major advantage of tumor tissue slice culture is the ability to culture primary human tumors
from established xenografts or directly from patient material with a minimum of disruption and
processing of the tumor. For practical reasons and to robustly validate multiple culture conditions, the
PREDECT consortium chose to use largely xenografted tumors from well-characterized human cell lines
(CDX), transplantable patient-derived xenografts (PDX), or GEMM-derived tumors, all as surrogates for
human primary tumors. By providing an abundance of ‘biologically similar’ tissue, these models allowed
for repeat experimentation and tight control of sampling technique important for the optimization and
validation process that could not have been easily met if primary human tumors had been used.
Below, some approaches are described that were implemented to monitor the impact of culture
methods on tissue viability and integrity, and to analyze the impact of cultivation on tumor cell biology.
Tumor slices were FFPE embedded and stained by IHC to assess a variety of biomarkers and the
induction of stress markers was assessed by analysis of gene expression.
IHC-based qualitative analysis
The impact of two parameters, mechanical support and physiological oxygen levels, were tested in the
ﬁrst instance. For the former, tumor slices were cultured either immersed in media, ‘ﬂoating’, or at an air-
liquid interface using an organotypic ﬁlter support, ‘ﬁlter’. For the latter, slices were cultivated either at
physiological (3–4%, low, L) or atmospheric (21%, A) oxygen concentrations. A basic pathological
examination of H&E stained sections of FFPE-embedded tissue slices, combined with a semi-quantitative
assessment of biomarker expression by IHC, was used to evaluate the cultivation parameters.
The use of an organotypic ﬁlter support was shown to be superior to the ‘ﬂoating’ method, across all
tumor types tested. Features of the ‘in vivo’ parental tumor were maintained with greater ﬁdelity using the
‘ﬁlter’ method (Supplementary Fig. S8).
Whereas the H&E staining clearly showed that cell viabilities in MCF7 CDX and lung GEMM tumors
were retained only in atmospheric oxygen conditions, the results were less conclusive for the prostate
PC295 PDX, and the lung H1437 CDX, and lung 1,647 PDX models. A quantitative gene expression-
based
approach (described below) was therefore applied to assess the optimal oxygen levels across the range of
models.
Gene expression-based quantitative analysis
In order to monitor the viability and functionality of the cultured tissue slices at a molecular level, a set of
genes containing key stress and viability biomarkers was assembled (full gene list with annotation is
included in the Supplementary Materials). Expression of the selected genes was analyzed from slices
cultured at various conditions, and compared to parental tumors, that had been snap-frozen at necropsy,
and to a tissue slice frozen immediately after slicing (d0 slice).
Very few gene expression changes were induced by the act of tumor tissue slicing (Supplementary Fig.
S9). Amongst the cultured slices, the lowest number of stress genes was induced in tumor tissue slices
cultivated in atmospheric oxygen and on a ﬁlter support. Thus this condition was not only optimal for
tissue viability of MCF7 and the lung GEMM model (see above), but also the prostate PC295 PDX, and
lung H1437 CDX and 1,647 PDX tumor models. In line with the histopathological observations, gene
changes increased across the models when cultured without a ﬁlter support, or with a ﬁlter support but at
low (physiological) oxygen conditions (Supplementary Fig. S9). Euclidean distance scores, generated by
comparing the gene expression values of cultured slices with the gene expression values of the in vivo
parental tumor, showed that slices cultured in atmospheric oxygen using a ﬁlter support were more
representative of the in vivo situation (Supplementary Fig. S10).
Loco-regional biomarker expression across slices
In most studies, if histological analysis was performed on tumor tissue slices, the analysis was done on the
upward-facing surface of the slice (i.e., the air-interface of the ﬁlter supported slices). In order to assess the
www.nature.com/sdata/
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accuracy of the optimized tissue slice protocol to capture and maintain tumor heterogeneity more broadly,
biomarker expression was examined also across the depth of the tissue slice. To this end, tumor slices were
embedded horizontally to be sectioned from the air-interface towards the ﬁlter side, or vertically and
sectioned to incorporate ﬁlter- to air-side within one FFPE section (Fig. 10). Horizontal sectioning of lung
GEMM tissue slices revealed that viability of the sections decreased with the distance to the air-side (Fig.
10a). Also AR expression in a prostate PDX model decreased in sections closer to the ﬁlter support (Fig.
10b). When sectioned vertically, the analysis conﬁrmed a bias in the expression of key biomarkers within
each tissue slice with a propensity for viability markers to be found closer to the air-interface, while stress
biomarkers (such as HIF1α) were found at the ﬁlter-interface (Fig. 10c–e). This led us to conclude and advise
that a cross-section through the tissue slice (preferably by vertically embedding) should be examined to allow
proper evaluation of tissue slice quality and to assess changes in biomarker expression.
Overall, the ﬁndings of these validation approaches suggest that oxygen levels and access to oxygen
appear to the main contributory factors to cell viability upon culture of tissue slices. This is likely
reﬂecting the fact that the majority of xenografted or GEMM tumors exhibit a proﬁcient oxygen supply,
through extensive and often immature vasculature, which is lost upon excision from the murine host.
Usage Notes
The use, advantages and disadvantages of the 2D/3D models and tissue slices have been discussed
elsewhere5,9. Table 6 is, therefore, focused on a comparison of tissue slices and 2D/3D models.
However, all models described in this report are subject to changes and improvements, so our current
assessment may change over time.
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